We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Expert Opinion / Cases · March 26, 2021

Invasive Ductal Carcinoma of the Left Breast

Giurgiu Silvia


Discuss This item Follow

No comments yet, be the first to start the discussion!

  • Maria Ester Dominguez

    I think it´s the right choice

  • Jayaprakash Madhavan

    She does not require any additional treatment but she needs evaluation of both bone and cardiac health

  • Giurgiu Silvia

    Thank you

  • mohamad kadri

    She doesn't need any additional therapy

  • oscar aballay

    Doesn’t need another treatment

  • Kiley Loh

    I would consider switching the tamoxifen to an aromatase inhibitor Recommend germline genetic testing

  • Bogdan Cristian Dinu

    because 25% of breast cancer cases are in liason with high level of cholesterol check it and if it is high use Simvastatin .

  • Andrea Breeding

    Treatment is adequate. I agree with genetic testing.

  • Giurgiu Silvia

    Already done genetic testing for BRCA, PALB... and all negative.

  • Wang Hsin-Fang

    She needs to receive 3 more adjuvant chemotherapy .

  • Apr 16, 2021

    Pending Moderator approval.

Further Reading